Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 31 July 2023 31 July 2024 31 July 2024 15039154 Dr Muataz Amare iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15039154 2023-07-30 15039154 2024-07-31 15039154 2023-07-31 2024-07-31 15039154 frs-core:CurrentFinancialInstruments 2024-07-31 15039154 frs-bus:PrivateLimitedCompanyLtd 2023-07-31 2024-07-31 15039154 frs-bus:FilletedAccounts 2023-07-31 2024-07-31 15039154 frs-bus:Micro-entities 2023-07-31 2024-07-31 15039154 frs-bus:AuditExempt-NoAccountantsReport 2023-07-31 2024-07-31 15039154 frs-bus:Director1 2023-07-31 2024-07-31
Registered number: 15039154
Dramare Limited
Unaudited Financial Statements
For The Year Ended 31 July 2024
The Accountancy People Manchester Limited
Balance Sheet
Registered number: 15039154
2024
£
Fixed assets 789
Current assets 143,670
Creditors: Amounts Falling Due Within One Year (34,736 )
NET CURRENT ASSETS 108,934
TOTAL ASSETS LESS CURRENT LIABILITIES 109,723
Accruals and deferred income (483 )
NET ASSETS 109,240
CAPITAL AND RESERVES 109,240

Notes

1. General Information
Dramare Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15039154 . The registered office is 386 Buxton Road, Stockport, SK2 7BY.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Muataz Amare
Director
5 September 2024